4//SEC Filing
Baksht Jonathan 4
Accession 0000950170-24-137665
CIK 0001527508other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 11:20 AM ET
Size
8.6 KB
Accession
0000950170-24-137665
Insider Transaction Report
Form 4
Baksht Jonathan
Chief Financial Officer
Transactions
- Award
Common Stock
2024-12-16+207,839→ 456,680 total - Tax Payment
Common Stock
2024-12-16$17.32/sh−134,468$2,328,986→ 322,212 total - Award
Common Stock
2024-12-16+6,692→ 248,841 total
Footnotes (3)
- [F1]Represents additional shares acquired by the reporting person in connection with the settlement of dividend equivalent rights upon the vesting of 89,004 restricted stock units that were otherwise scheduled to vest on March 2, 2025 and May 27, 2025 but that were accelerated into 2024.
- [F2]Represents shares acquired by the reporting person in connection with the vesting and settlement of 93,843 performance share units that were granted in 2022, together with associated dividend equivalent rights, that were otherwise scheduled to vest on May 27, 2025, but that were accelerated into 2024. Pursuant to the Agreement and Plan of Merger, dated as of December 9, 2024, by and among the Issuer, Novolex Holdings, LLC and Alpha Lion Sub, Inc., and the determination by the Compensation Committee of the Issuer's Board of Directors in relation to achievement of the performance criteria, the performance share units were settled at 200% of target.
- [F3]The reported securities were withheld to satisfy the reporting person's tax liability in connection with the vesting of the aforementioned restricted stock units and performance share units.
Documents
Issuer
Pactiv Evergreen Inc.
CIK 0001527508
Entity typeother
Related Parties
1- filerCIK 0001658406
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 11:20 AM ET
- Size
- 8.6 KB